Dhaval Packaging IPO Review: A Real Profit Jump Worth Understanding Before It Opens

Quick Answer

Dhaval Packaging, a Gujarat based manufacturer of In-Mold Labeling containers and industrial pipe protection caps, opens for subscription on 30 July, closing 3 August with listing expected 6 August. The business has a genuinely specialised niche, most of its revenue comes from IML containers used in dairy, sweets, and ready-to-eat food packaging, backed by in-house label production. The one thing worth understanding clearly before applying: Dilip Davda's pre-IPO review specifically flagged the company's recent profit growth as a "boosted bottom line" that "raises eyebrows" given how competitive and fragmented this packaging segment is, a caution worth weighing alongside the otherwise solid growth story.

Key Details at a Glance

What Does Dhaval Packaging Ltd Do?

Picture the tub of ice cream or the tray of sweets from a dairy shop, where the label isn't a sticker but seems built directly into the container itself. That's In-Mold Labeling, and it's the core of what Dhaval Packaging manufactures. You can track this and other IPO GMP data on the IPO GMP Live homepage.

Founded in Gujarat in 2015, the company positions itself as a design-led packaging partner, working with clients from early product development through artwork, mold and label harmonisation, and into steady-state production supply. IML containers make up over 73% of FY25 revenue, serving dairy, sweets, ice cream, bakery, and ready-to-eat food brands, while the remaining share comes from SAW pipe protection plastic End Caps used in industrial applications like oil and gas and infrastructure. Its facility spans more than 60,000 square feet with 21 machines dedicated to IML production, and label manufacturing is kept in-house through backward integration with a group entity, Octa Labels, giving it more control over quality and cost than a company relying on third-party label suppliers.

How Strong Are the Financials, and Why Did Davda Flag Them?

Revenue grew steadily, from Rs 48.08 crore in FY24 to Rs 52.43 crore in FY25 to Rs 65 crore in FY26, roughly 9% then 24% growth. Profit told a different story: it jumped from Rs 1.55 crore in FY24 to Rs 6.04 crore in FY25, an approximately 290% increase, well ahead of that year's modest revenue growth, before growing a further 33% to Rs 8.04 crore in FY26.

That gap, profit growing far faster than revenue in FY25 specifically, is exactly what Dilip Davda's pre-IPO review flagged as worth scrutinising, describing it as a "boosted bottom line" that "raises eyebrows" for a company operating in what he called a highly competitive and fragmented segment. This doesn't necessarily mean anything is wrong, margin improvement from better capacity utilisation, mix shift toward higher-margin IML work, or the backward integration into label production could all be legitimate, disclosed explanations, but it's worth checking the RHP for the specific driver before assuming the FY25 pace of margin expansion simply continues.

Should You Apply for the Dhaval Packaging IPO?

Conservative investors: The specialised IML niche and in-house label integration are genuine positives, but Davda's specific caution about the recent profit jump, combined with operating in a competitive, fragmented segment, suggests waiting to see the final subscription and GMP trends once the issue actually opens would be a reasonable, lower-risk approach.

Moderate investors: One reviewer's fair, conditional framing, that the IPO looks suitable for both listing-gain seekers and selective long-term investors depending on how GMP and subscription develop, is a sensible way to approach this. Understanding what specifically drove the FY25 margin jump would help clarify which camp you fall into.

Aggressive investors: A design-led packaging business with real backward integration and a growing footprint in food-grade IML containers offers a credible niche growth story if the recent margin improvement proves durable rather than a one-off. The competitive, fragmented nature of the packaging industry that Davda specifically flagged is the main risk to weigh against that growth thesis.

Honest take. Dhaval Packaging brings a genuinely specialised, defensible niche to this IPO, in-house IML label production is a real point of differentiation in a commoditised packaging industry. But Dilip Davda's specific caution about the FY25 profit jump deserves real weight, a "boosted bottom line" comment from an experienced reviewer isn't something to wave past just because the growth numbers look good on the surface. My honest read is this is worth watching through the actual subscription window before forming a firm view, checking whether institutional (QIB) demand shows real conviction once bidding opens, rather than applying purely on the strength of the recent profit trajectory.

Where Will the IPO Money Go?

The large majority of the fresh issue, Rs 27.19 crore, is earmarked for partly financing a new manufacturing facility at Sanand-II Industrial Estate in Ahmedabad district, directly expanding production capacity beyond the current 60,000 square foot facility. Rs 3.75 crore is set aside for repaying or prepaying existing secured borrowings, with the remainder for general corporate purposes. This is a clearly growth-oriented allocation, weighted toward physical capacity expansion for a business that's already shown strong recent demand.

Contact Details

Company: Dhaval Packaging Ltd.

Location: Gujarat (new facility planned at Sanand-II Industrial Estate, Ahmedabad district)

Business: Design-led manufacturing of In-Mold Labeling (IML) food containers and SAW pipe protection plastic End Caps, serving food, FMCG, and industrial sectors

Registrar: KFin Technologies Ltd.

Lead Manager: Rarever Financial Advisors Pvt. Ltd.

Listing: BSE, SME platform (expected 6 August 2026)

This page is not investment advice. GMP is indicative, unofficial, and had not meaningfully started as of this writing. Please consult a SEBI registered financial advisor before investing, and check the latest subscription and GMP figures once the issue opens on 30 July.